ES2170501T3 - Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica. - Google Patents

Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.

Info

Publication number
ES2170501T3
ES2170501T3 ES98925588T ES98925588T ES2170501T3 ES 2170501 T3 ES2170501 T3 ES 2170501T3 ES 98925588 T ES98925588 T ES 98925588T ES 98925588 T ES98925588 T ES 98925588T ES 2170501 T3 ES2170501 T3 ES 2170501T3
Authority
ES
Spain
Prior art keywords
protein
pharmaceutical composition
activity
glycyrdic
antivirical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98925588T
Other languages
English (en)
Inventor
Raffaello Pompei
Mario Pinza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2170501T3 publication Critical patent/ES2170501T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición farmacéutica que comprende ácido glicirrícico y al menos una proteína que presenta una actividad antiviral.
ES98925588T 1997-05-14 1998-05-06 Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica. Expired - Lifetime ES2170501T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
ES2170501T3 true ES2170501T3 (es) 2002-08-01

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98925588T Expired - Lifetime ES2170501T3 (es) 1997-05-14 1998-05-06 Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.

Country Status (27)

Country Link
US (1) US6329339B1 (es)
EP (1) EP0980254B1 (es)
JP (2) JP2001525814A (es)
KR (1) KR100592193B1 (es)
CN (1) CN1114447C (es)
AR (1) AR012849A1 (es)
AT (1) ATE212232T1 (es)
AU (1) AU740944B2 (es)
BG (1) BG64748B1 (es)
CA (1) CA2289550A1 (es)
CZ (1) CZ291932B6 (es)
DE (1) DE69803565T2 (es)
DK (1) DK0980254T3 (es)
EA (1) EA003126B1 (es)
ES (1) ES2170501T3 (es)
GE (1) GEP20022672B (es)
HK (1) HK1028347A1 (es)
HU (1) HU224956B1 (es)
IL (2) IL132651A0 (es)
IT (1) IT1291366B1 (es)
PL (1) PL189218B1 (es)
PT (1) PT980254E (es)
SK (1) SK283584B6 (es)
TR (1) TR199902730T2 (es)
UA (1) UA63955C2 (es)
WO (1) WO1998051334A1 (es)
ZA (1) ZA983917B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
WO2003088914A2 (en) * 2002-04-18 2003-10-30 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
EP1668035A2 (en) * 2003-09-11 2006-06-14 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
WO2007084253A2 (en) * 2005-11-28 2007-07-26 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
EP2608783B1 (en) * 2010-08-25 2018-09-19 Lurong Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
KR102437992B1 (ko) * 2014-02-21 2022-08-29 고쿠리츠 다이가쿠 호우징 도쿄 가이요우 다이가쿠 노로 바이러스 불활화제 및 그 제조 방법, 노로 바이러스 불활화 방법, 노로 바이러스 불활화용 라이소자임류의 제조 방법, 노로 바이러스 감염의 예방약 또는 치료약, 그리고 노로 바이러스 불활화용 피부 외용제
EP3419629A4 (en) * 2016-02-25 2019-10-30 Applied Biological Laboratories, Inc. COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112805027B (zh) * 2020-04-27 2023-10-10 广州新创忆药物临床研究有限公司 一种抗新冠病毒感染的药物与应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
MX2021005280A (es) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
EP0980254B1 (en) 2002-01-23
SK154499A3 (en) 2000-08-14
AU7764698A (en) 1998-12-08
IL132651A (en) 2006-10-31
CZ291932B6 (cs) 2003-06-18
SK283584B6 (sk) 2003-10-07
DE69803565T2 (de) 2002-08-08
IL132651A0 (en) 2001-03-19
IT1291366B1 (it) 1999-01-07
DK0980254T3 (da) 2002-05-06
ITMI971119A0 (es) 1997-05-14
UA63955C2 (uk) 2004-02-16
EA199901024A1 (ru) 2000-06-26
KR100592193B1 (ko) 2006-06-23
HUP0002985A2 (hu) 2001-01-29
PL336802A1 (en) 2000-07-17
ZA983917B (en) 1998-11-09
AR012849A1 (es) 2000-11-22
GEP20022672B (en) 2002-04-25
CA2289550A1 (en) 1998-11-19
CZ399199A3 (cs) 2000-04-12
JP2001525814A (ja) 2001-12-11
HK1028347A1 (en) 2001-02-16
ITMI971119A1 (it) 1998-11-14
WO1998051334A1 (en) 1998-11-19
EP0980254A1 (en) 2000-02-23
KR20010012419A (ko) 2001-02-15
PT980254E (pt) 2002-07-31
HUP0002985A3 (en) 2001-04-28
AU740944B2 (en) 2001-11-15
CN1255859A (zh) 2000-06-07
DE69803565D1 (de) 2002-03-14
JP2009102370A (ja) 2009-05-14
US6329339B1 (en) 2001-12-11
EA003126B1 (ru) 2003-02-27
PL189218B1 (pl) 2005-07-29
BG64748B1 (bg) 2006-02-28
CN1114447C (zh) 2003-07-16
HU224956B1 (en) 2006-04-28
TR199902730T2 (xx) 2000-02-21
ATE212232T1 (de) 2002-02-15
BG103968A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
ES2170501T3 (es) Composicion farmaceutica antivirica que comprende acido glicirrizico y al menos una proteina que posee actividad antivirica.
NL300190I1 (nl) Farmaceutische formuleringen met darifenacine.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
BR9611367A (pt) Formulação farmacêutic liofilizada estável
ID24654A (id) Formulasi farmasi omeprazola
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69810612D1 (de) Pharmazeutische Zusammensetzungen mit Plasmaproteinen
ID21259A (id) Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif
DE69426415T2 (de) Intrapulmonares hormonabgabesystem
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
DE69525148D1 (de) Pharmazeutische formulierung
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
DK0850426T3 (da) Transpondearrangement
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
BR9610396A (pt) Formulação farmacêutica
DE69014166D1 (de) Aktive Matrix.
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DE68917651D1 (de) Aktiv-Matrix-Anzeigevorrichtung.
TR199501082A2 (tr) Farmasötik formülasyonlar.
DE69019683D1 (de) Aktive Wiedergabeanordnung.
FI955605A (fi) Aryloivia lääkkeitä
DE69013610D1 (de) Aktives Matrixanzeigegerät.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 980254

Country of ref document: ES